Getting started with NovoSeven® RT

Connect to tools and resources that can help you get off to a good start with NovoSeven® RT.

Christina and son, Caden has congenital hemophilia with inhibitors



 

Get your NovoSeven® RT Starter Kit

Your kit is designed to introduce you to NovoSeven® RT treatment. You’ll find product information, resources and support, plus easy-to-read mixing information. You’ll also receive a Web key that launches the NovoSeven® RT with MixPro® instructional video. The kit also includes a sample device to let you practice mixing a dose before you start treatment. Please keep in mind that this Starter Kit does not contain any real product and must not be administered in humans. To receive a kit, call 1-877-NOVO-777 (1-877-668-6777).


 



 


 

Learn how to mix a dose

NovoSeven® RT with MixPro® can be prepared in 3 steps: attach, twist, and mix. You will be guided through the process in this video as you watch a dose being mixed. You should not attempt to self-administer unless you have been taught how by your doctor or hemophilia treatment center.


Please see Prescribing Information for complete Instructions For Use.


 



 


 

Need to treat on the go?

The NovoSeven® RT Travel Kit will fit right into your active lifestyle. This portable, reusable travel case makes storing supplies easy, at home or on the go. To get a Ready-to-Travel Case, call 1-877-NOVO-777 (1-877-668-6777).


 



 

NovoSecure™

Get access to support designed for the bleeding disorders community. Visit MyNovoSecure.com or call 1-844-NOVOSEC (1-844-668-6732) to learn more and enroll. Novo Nordisk product usage is not an eligibility requirement of NovoSecure™.


 


Selected Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and people with Glanzmann's thrombasthenia who have a decreased or absent response to platelet transfusions
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia

Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

  • NovoSeven® RT should be used with caution if you have an increased risk for blood clots, such as with disseminated intravascular coagulation (DIC), clogged arteries, crush injury, septicemia (an infection in the blood), uncontrolled bleeding after giving birth, history of heart disease, liver disease, limited movement following surgery, in elderly people, in newborns, or if you are taking aPCCs/PCCs (activated or nonactivated prothrombin complex concentrates) with NovoSeven® RT.
  • Allergic reactions, including serious whole body allergic reactions, have been reported with NovoSeven® RT. Tell your healthcare provider if you are allergic to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. If you think you are having an allergic reaction, call your healthcare provider right away. Some signs of allergic reaction may include shortness of breath, rash, itching, redness of the skin, and fainting/dizziness.
  • People with Factor VII deficiency should be monitored by their healthcare provider for antibodies, which can cause NovoSeven® RT to stop working properly.

Side Effects

  • The most common and serious side effects are blood clots.
  • Tell your healthcare provider about any side effects that bother you or do not go away.

Use with Other Drugs

  • Blood clots may occur if NovoSeven® RT is given with Coagulation Factor XIII (13).

Please click here for Prescribing Information and Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

NovoSeven® RT is a prescription medication. Novo Nordisk provides patient assistance for those who qualify. Please call 1-877-NOVO-777 (1-877-668-777) to learn more about Novo Nordisk assistance programs.